 |
Cynthia Gail Leichman, M.D., F.A.C.P.
Research Director
Providing patients with access to clinical trials is an integral part of services offered at the Comprehensive
Cancer Center. Currently there are more than 45 research studies in place in collaboration with a network of
Aptium Oncology-managed cancer centers throughout the country. Some 120 oncologists participate within this
network. These physicians conduct investigational-initiated trials in addition to working with national
cooperative groups and major pharmaceutical and biotechnology companies on Phase I - IV clinical trials.
CCC Research Collaboration:
- Approximately 23 Pharmaceutical Companies
- National Cancer Institute (NCI) Sponsored National Cooperative Groups
- Southwest Oncology Group
- National Surgical Adjuvant Breast and Bowel Project
- Clinical Trials Support Unit
- International Breast Cancer Study Group
- North Central Cancer Treatment Group
- National Cancer Institute of Canada
- Radiation Therapy Oncology Group
- Eastern Cooperative Oncology Group
- Cancer and Leukemia Group B
- Aptium Oncology Research Network
- University of Southern California
- Accelerated Community Oncology Research Network
- NYU Cancer Institute
Types of Trials:
- Physicians enroll onto clinical trials in medical oncology, surgical oncology and radiation oncology
- Phase I - IV
- Investigator Initiated Trials (written by CCC physicians)
- Treatment Trials
- Prevention Trials
- Prospective Observation Studies
- Tissue Collection Studies
- Pharmacokinetic Studies
- Breast, Colorectal, Esophageal, Prostate, Leukemia, Lymphoma, Lung, Myeloma and Melanoma
For more information on clinical trials at the Comprehensive Cancer Center, please call: (760) 416-4734 or contact us.
|
 |
